tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Maneka Mirchandaney, 9 are a BUY (69.23%), 4 are a HOLD (30.77%).
Analyst Maneka Mirchandaney, carries an average stock price target met ratio of 56.67% that have a potential upside of 26.31% achieved within 198 days.
Maneka Mirchandaney’s has documented 26 price targets and ratings displayed on 5 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on CRNX, Crinetics Pharmaceuticals at 12-Feb-2024.
Analyst best performing recommendations are on SGEN (SEAGEN).
The best stock recommendation documented was for SGEN (SEAGEN) at 5/17/2021. The price target of $153 was fulfilled within 3 days with a profit of $5.02 (3.39%) receiving and performance score of 11.31.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Nov-2021
$96
$60.43 (169.89%)
$105
20 days ago
(02-Mar-2026)
9/21 (42.86%)
$55.32 (135.99%)
394
Buy Since 12-Jan-2026
$67
$31.43 (88.36%)
$40
2 months 10 days ago
(12-Jan-2026)
1/2 (50%)
$11.65 (21.05%)
42
Buy Since 16-Jan-2024
$80
$44.43 (124.91%)
$77
2 months 16 days ago
(06-Jan-2026)
1/4 (25%)
$34.05 (74.10%)
113
Buy Since 30-Aug-2023
$87
$51.43 (144.59%)
$73
5 months 20 days ago
(30-Sep-2025)
5/10 (50%)
$45.35 (108.88%)
146
Buy Since 13-Aug-2018
$88
$52.43 (147.40%)
$39
5 months 21 days ago
(29-Sep-2025)
2/3 (66.67%)
$44.49 (102.25%)
1326
What Year was the first public recommendation made by Maneka Mirchandaney?
